EdgarLookup

Karyopharm Therapeutics Inc. — All Filings

1,000 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 10-Q/A 144 3 4 4/A 424B3 424B4 424B5 5 8-A12B 8-K ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRSLTR EFFECT POS AM POSASR PRE 14A RW S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC TO-C SC TO-I SC TO-I/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 FORM 4 SUBMISSION 0001209191-22-036812 Jun 14, 2022 Jun 13, 2022
4 FORM 4 SUBMISSION 0000899243-22-021957 Jun 10, 2022 Jun 8, 2022
4 FORM 4 SUBMISSION 0000899243-22-021477 Jun 8, 2022 Jun 7, 2022
4 FORM 4 SUBMISSION 0000899243-22-021234 Jun 6, 2022 Jun 3, 2022
S-8 S-8 0001193125-22-166718 Jun 3, 2022
8-K 8-K 0001193125-22-157447 May 23, 2022 May 19, 2022
4 FORM 4 SUBMISSION 0001209191-22-030983 May 20, 2022 May 19, 2022
4 FORM 4 SUBMISSION 0001209191-22-030972 May 20, 2022 May 19, 2022
4 FORM 4 SUBMISSION 0001209191-22-030986 May 20, 2022 May 19, 2022
4 FORM 4 SUBMISSION 0001209191-22-030953 May 20, 2022 May 19, 2022
4 FORM 4 SUBMISSION 0001209191-22-030956 May 20, 2022 May 19, 2022
4 FORM 4 SUBMISSION 0001209191-22-030970 May 20, 2022 May 19, 2022
4 FORM 4 SUBMISSION 0001209191-22-030978 May 20, 2022 May 19, 2022
DEFA14A DEFA14A 0001193125-22-148265 May 12, 2022
SC 13G 0001493152-22-012564 May 9, 2022
4 FORM 4 SUBMISSION 0001209191-22-027344 May 5, 2022 May 4, 2022
8-K 8-K 0001193125-22-141284 May 5, 2022
10-Q 10-Q 0000950170-22-007564 May 5, 2022 Mar 31, 2022
4 FORM 4 SUBMISSION 0001209191-22-026425 May 2, 2022 Apr 29, 2022
3 FORM 3 SUBMISSION 0001209191-22-026106 Apr 29, 2022 Apr 19, 2022
DEF 14A DEF 14A 0000950170-22-005492 Apr 8, 2022 May 19, 2022
DEFA14A DEFA14A 0001193125-22-099758 Apr 8, 2022
4 FORM 4 SUBMISSION 0001209191-22-021755 Mar 31, 2022 Mar 29, 2022
8-K 8-K 0001193125-22-087458 Mar 29, 2022 Mar 28, 2022
8-K 8-K 0001193125-22-086854 Mar 28, 2022 Mar 22, 2022
4 FORM 4 SUBMISSION 0001209191-22-014628 Mar 2, 2022 Feb 28, 2022
4 FORM 4 SUBMISSION 0001209191-22-014629 Mar 2, 2022 Feb 28, 2022
4 FORM 4 SUBMISSION 0001209191-22-014619 Mar 2, 2022 Feb 28, 2022
4 FORM 4 SUBMISSION 0001209191-22-014622 Mar 2, 2022 Feb 28, 2022
4 FORM 4 SUBMISSION 0001209191-22-014621 Mar 2, 2022 Feb 28, 2022
4 FORM 4 SUBMISSION 0001209191-22-014623 Mar 2, 2022 Feb 28, 2022
4 FORM 4 SUBMISSION 0001209191-22-014624 Mar 2, 2022 Feb 28, 2022
4 FORM 4 SUBMISSION 0001209191-22-014626 Mar 2, 2022 Feb 28, 2022
10-K 10-K 0000950170-22-002548 Mar 1, 2022 Dec 31, 2021
S-8 FORM S-8 0001193125-22-057836 Feb 28, 2022
4 FORM 4 SUBMISSION 0001209191-22-011650 Feb 22, 2022 Feb 17, 2022
4 FORM 4 SUBMISSION 0001209191-22-011636 Feb 22, 2022 Feb 17, 2022
4 FORM 4 SUBMISSION 0001209191-22-011639 Feb 22, 2022 Feb 17, 2022
4 FORM 4 SUBMISSION 0001209191-22-011643 Feb 22, 2022 Feb 17, 2022
SC 13G/A 0001306923-22-000012 Feb 14, 2022
SC 13G/A SC 13G/A 0001193125-22-036941 Feb 11, 2022
SC 13G/A AMENDMENT NO. 7 TO SCHEDULE 13G 0001213900-22-006930 Feb 11, 2022
4 FORM 4 SUBMISSION 0001209191-22-008119 Feb 9, 2022 Feb 7, 2022
4 FORM 4 SUBMISSION 0001209191-22-008124 Feb 9, 2022 Feb 7, 2022
4 FORM 4 SUBMISSION 0001209191-22-008126 Feb 9, 2022 Feb 7, 2022
4 FORM 4 SUBMISSION 0001209191-22-008128 Feb 9, 2022 Feb 7, 2022
4 FORM 4 SUBMISSION 0001209191-22-008130 Feb 9, 2022 Feb 7, 2022
8-K 8-K 0001193125-22-030469 Feb 8, 2022
SC 13G 0000834237-22-002761 Jan 27, 2022
SC 13G/A 0000834237-22-001166 Jan 26, 2022